Published in J Neurol Sci on April 15, 2000
Vascular dementia: prevention and treatment. Clin Interv Aging (2006) 0.87
Antileishmanial activity and ultrastructural alterations of Leishmania (L.) chagasi treated with the calcium channel blocker nimodipine. Parasitol Res (2009) 0.84
Recent updates on subcortical ischemic vascular dementia. J Stroke (2014) 0.82
Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke: Traditional and Bayesian Network Meta-analysis of Randomized Trials. Medicine (Baltimore) (2016) 0.79
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol (1995) 3.23
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Vagal non-adrenergic inhibition of guinea-pig stomach. J Physiol (1971) 2.29
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology (2007) 2.25
Small-vessel disease relates to poor poststroke survival in a 12-year follow-up. Neurology (2011) 2.19
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01
Epidemiology of distal symmetrical neuropathies in the Italian elderly. Neurology (2007) 1.94
Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem (2001) 1.87
Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol (2002) 1.86
White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol (1993) 1.86
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
The effect of catecholamines and sympathetic stimulation on the release of acetylcholine from the guinea-pig colon. Br J Pharmacol (1969) 1.81
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand (1991) 1.77
Short Portable Mental Status Questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc (1987) 1.76
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma. Amyloid (2000) 1.75
CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology (2005) 1.73
Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology (2000) 1.73
Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun (1999) 1.70
Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol (1999) 1.68
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology (1999) 1.64
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol (2009) 1.64
Laparoscopic cholecystectomy in the third trimester of pregnancy. Am Surg (1996) 1.60
Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol (2001) 1.59
Intestinal perforation as a long-term complication of plug and mesh inguinal hernioplasty: case report. Hernia (2004) 1.58
Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. Int J Clin Pract (2004) 1.58
Prognostic factors of malignant mesothelioma of the pleura. Cancer (1993) 1.58
Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group. Stroke (1999) 1.56
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke (1997) 1.56
Moderate alcohol consumption and loss of cerebellar Purkinje cells. BMJ (1994) 1.53
Age-related white matter changes and cognitive impairment. Ann Neurol (2000) 1.52
The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction. Int J Clin Pract (2010) 1.50
A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology (1998) 1.50
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology (2004) 1.47
Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest (1993) 1.46
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology (2007) 1.46
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol Scand (1994) 1.44
Allergic vasculitis Gougerot-Ruiter syndrome. Arch Dermatol (1967) 1.44
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology (2007) 1.43
TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrob Agents Chemother (2000) 1.41
A new selective antagonist of the nociceptin receptor. Br J Pharmacol (1998) 1.41
Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group. Neuroepidemiology (1993) 1.40
Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure. Eur Respir J (2005) 1.39
Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr (1993) 1.37
A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena. Acta Neurol Scand (1987) 1.36
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36
Clinical determinants of poststroke dementia. Stroke (1998) 1.36
Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry (1987) 1.36
Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol Med (1995) 1.34
Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke (1997) 1.33
White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry (2007) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc (2000) 1.30
Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol (1978) 1.30
The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry (2005) 1.30
White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol (1999) 1.29
Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand (1990) 1.29
CT evaluation of coverage and congruency of the hip prior to osteotomy. Clin Orthop Relat Res (1988) 1.28
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
Executive functions and speed of mental processing in elderly patients with frontal or nonfrontal ischemic stroke. Eur J Neurol (1999) 1.27
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology (1997) 1.27
Vascular dementia due to cardiac arrhythmias and systemic hypotension. Acta Neurol Scand (1987) 1.27
Dementia among medical inpatients. Evaluation of 2000 consecutive admissions. Arch Intern Med (1986) 1.27
Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry (1985) 1.26
Further evidence for the presence of non-adrenergic inhibitory structures in the guinea-pig colon. Eur J Pharmacol (1968) 1.26
Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 1.26
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report. Pediatrics (2001) 1.24
White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry (2005) 1.24
Alternative promoter and 5' exon generate a novel Gs alpha mRNA. J Biol Chem (1990) 1.23
Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am Heart J (1974) 1.22